For citations:
Kurenkov AL, Kuzenkova LM, Bursagova BI, Chernikov VV, Agranovich OV, Khachatryan LG, Kenis VM, Zherebtsova VA, Sarzhina MN, Odinaeva ND, Artemenko AR, Popova GA, Moroshek EA, Tabe EE, Nezhelskaya AA, Maksimenko AA, Akhadova LY, Indereikin MV, Duibanova NV, Tikhonova LV, Sapogovskiy AV, Gadzhialieva ZM, Grigorieva AV, Perminov VS, Fedonyuk ID, Kolpakchi LM, Kursakova AY, Tsurina NA. Russian consensus on the use of incobotulinumtoxinA in children with cerebral palsy for the treatment of spasticity and sialorrhea. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2022;14(2):117-125. https://doi.org/10.14412/2074-2711-2022-2-117-125
Email this article 